The synthesis and SAR of 2-amino-pyrrolo[2,3-d]pyrimidines: A new class of Aurora-A kinase inhibitors
K.J.M. Moriarty(Johnson & Johnson (United States)), Robert A. Galemmo(Johnson & Johnson (United States)), Holly K. Koblish(Wilmington University), Carl Crysler(Johnson & Johnson (United States)), Anna C. Maroney(AbbVie (United States)), Ehab M. Khalil(Johnson & Johnson (United States)), Farah Ali(Johnson & Johnson (United States)), Dana L. Johnson(Johnson & Johnson (United States)), Thomas Garrabrant(Johnson & Johnson (United States)), Jahanvi Maisuria(Johnson & Johnson (United States)), Ioanna P. Petrounia(Johnson & Johnson (United States))
Cited by 65
Related Papers
Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells
|Journal of Medicinal Chemistry|2005|430
Motoneuron Apoptosis Is Blocked by CEP-1347 (KT 7515), a Novel Inhibitor of the JNK Signaling Pathway
|Journal of Neuroscience|1998|293
The MLK Family Mediates c-Jun N-Terminal Kinase Activation in Neuronal Apoptosis
|Molecular and Cellular Biology|2001|268
beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation
|Journal of Neurochemistry|2001|223